Home  |  Contact

UniProtKB/Swiss-Prot O60383: Variant p.Pro103Ser

Growth/differentiation factor 9
Gene: GDF9
Chromosomal location: 5q31.2
Variant information

Variant position:  103
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Unclassified
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Proline (P) to Serine (S) at position 103 (P103S, p.Pro103Ser).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and hydrophobic (P) to small size and polar (S)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Premature ovarian failure 14 (POF14) [MIM:618014]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:16278619, ECO:0000269|PubMed:16645022, ECO:0000269|PubMed:16954162, ECO:0000269|PubMed:17156781, ECO:0000269|PubMed:17482612, ECO:0000269|PubMed:19438907, ECO:0000269|PubMed:29044499}. Note=The disease is caused by mutations affecting the gene represented in this entry.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  In POF14; unknown pathological significance; also found at higher frequency in mothers of dizygotic twins than in controls.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  103
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  454
The length of the canonical sequence.

Location on the sequence:   SRALHYMKKLYKTYATKEGI  P KSNRSHLYNTVRLFTPCTRH
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SRALHYMKKLYKTYATKEGIPKSNRSHLYNTVRLFTPCTRH

Mouse                         SRALYYMKKLYKTYATKEGVPKPSRSHLYNTVRLFSPCAQQ

Bovine                        DRALSYMKRLYKAYATKEGTPKSNRSHLYNTVRLFTPCAQH

Goat                          DRALRYMKRLYKAYATKEGTPKSNRRHLYNTVRLFTPCAQH

Sheep                         DRALRYMKRLYKAYATKEGTPKSNRRHLYNTVRLFTPCAQH

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Propeptide 25 – 319
Glycosylation 106 – 106 N-linked (GlcNAc...) asparagine


Literature citations

Novel variants in growth differentiation factor 9 in mothers of dizygotic twins.
Palmer J.S.; Zhao Z.Z.; Hoekstra C.; Hayward N.K.; Webb P.M.; Whiteman D.C.; Martin N.G.; Boomsma D.I.; Duffy D.L.; Montgomery G.W.;
J. Clin. Endocrinol. Metab. 91:4713-4716(2006)
Cited for: VARIANT POF14 SER-103; VARIANTS ILE-121; LEU-374 AND CYS-454; POSSIBLE INVOLVEMENT IN DIZYGOTIC TWINNING;

Growth differentiating factor-9 mutations may be associated with premature ovarian failure.
Kovanci E.; Rohozinski J.; Simpson J.L.; Heard M.J.; Bishop C.E.; Carson S.A.;
Fertil. Steril. 87:143-146(2007)
Cited for: VARIANT POF14 SER-103;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.